3 suspended. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Suspended 3 |
| Phase 1 | 1 | Suspended 1 |
Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Bariatric Surgery Placebo, Lidocaine 1%, Lidocaine 1.5% - Obesity, Bariatric Surgery Candidate | Phase 1 / Phase 2 | Suspended | Mansoura University | 180 | 2020-11-01 | 2020-09-04 |
| A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity Fenretinide, Placebo - Obesity, Insulin Resistance | Phase 2 | Suspended | University of California, San Diego | 21 | 2007-12-01 | 2021-02-10 |
| Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity combination metformin hydrochloride/ fluoxetine 500/20 mg, combination metformin hydrochloride/ fluoxetine 1000/20mg, Placebo Oral Tablet - Overweight and Obesity | Phase 2 | Suspended | Laboratorios Silanes S.A. de C.V. | 150 | 2017-09-01 |
Obesity (3) · Insulin Resistance (1)
Body Weight (3) · Nutrition Disorders (3) · Nutritional and Metabolic Diseases (3) · Overnutrition (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Metabolic Diseases (1)
Fenretinide (1) · Fluoxetine (1) · Lidocaine (1)
Laboratorios Silanes S.A. de C.V. (1) · Mansoura University (1) · University of California, San Diego (1)
Egypt (1) · Mexico (1) · United States (1)
Mario Chojkier, M.D. (1) · Mohamed R El Tahan, MD (1) · Samah El Kenany, MD (1)